Nifty 50

logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

GlaxoSmithKline Share Price

GLAXO

₹2,433

-7.40(-0.30%)
10th Jul 2026 | 3:28 PM
NSE : GLAXO
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

GlaxoSmithKline Performance

Price Movement

₹2433.00

₹2423.50

₹2453.80

↘ Today's Low↗ Today's High

1 Year Performance

₹2433.00

₹2088.10

₹3344.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,453.80
Low₹2,423.50
Open at₹2,441.00
Prev Close₹2,440.40
Volumes21.70 K
Avg Price₹2,441.19
Lower Circuit₹1,952.40
Upper Circuit₹2,928.40

Historical Performance

3M High₹2,529.90
3M Low₹2,088.10
1 Yr High₹3,319.90
1 Yr Low₹2,088.10
3 Yr High₹3,515.70
3 Yr Low₹1,377.25
5 Yr High₹3,515.70
5 Yr Low₹1,227.00

Summary

As of 10-07-2026 20:26, GlaxoSmithKline Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-2440.40 (-100.00%) from the previous close of ₹2440.4. The stock opened at ₹2441 and traded between ₹2423.5 and ₹2453.8, with a total traded volume of 21697 shares. The company has a market capitalization of ₹41341.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹3344 and ₹2088.1, respectively.

GlaxoSmithKline Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 39.9, EPS of ₹61.15, and book value of ₹18.20. Profitability indicators show ROE of 45.68% along with a dividend yield of 2.3%. GlaxoSmithKline Pharmaceuticals Ltd. has reported revenue of ₹3821.67 Cr and net profit of ₹1035.98 Cr.

GlaxoSmithKline Pharmaceuticals Ltd. technical indicators include Day RSI at 63.56, Day MFI at 75.88, Day ADX at 28.94. Additional indicators include Commodity Channel Index (CCI) at 74.2 and Williams %R at -24.07. Momentum indicators show Day MACD at 41, Day MACD Signal Line at 29.97, DayATR at 58.24. Rate of Change indicators for GlaxoSmithKline Pharmaceuticals Ltd. include ROC125 at -1.75 and ROC21 at 11.2.

Exponential moving averages include EMA5 at ₹2418.2, EMA10 at ₹2398.6, EMA12 at ₹2389.4, EMA20 at ₹2360.2, EMA26 at ₹2348.4, EMA50 at ₹2343.2, EMA100 at ₹2383.2, EMA200 at ₹2467. Simple moving averages include SMA5 at ₹2411.1, SMA10 at ₹2409.5, SMA20 at ₹2328.5, SMA30 at ₹2284.5, SMA50 at ₹2324.6, SMA100 at ₹2396.5, SMA150 at ₹2418.1, SMA200 at ₹2476.7.

Support levels for GlaxoSmithKline are placed at First Support ₹2404.87, Second Support ₹2369.33, Third Support ₹2341.37. Resistance levels are seen at First Resistance ₹2468.37, Second Resistance ₹2496.33, Third Resistance ₹2531.87. GlaxoSmithKline Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 4.62%, DII holding at 0%, public holding at 12.69%.

GlaxoSmithKline Fundamentals

Market Cap
High in industry
41,341.80 Cr.
PE Ratio (TTM)
Above industry Median
39.90
Dividend Yield
High in industry
2.30
Net Profit TTM
11.7% incr over last year
1,035.98
Net Profit Growth
11.7% incr over last year
1,035.98
PEG Ratio
High in industry
3.40
ROE
4% decr over last year
45.68
Operating Revenue TTM
3,821.67
Operating Revenue Growth
1.9% incr over last year
Book Value
High in industry
18.20
MFI
MFI Overbought
75.88
RSI
RSI is mid-range
63.56
EPS (TTM)
61.15
Debt to Equity
0
Face Value
10
Operating Profit Margin Qtr.
33
Operating Profit Qtr.
350.93
Net Profit Qtr.
277.86
Operating Revenue Qtr.
995.30
PB Ratio
18.20

GlaxoSmithKline Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Total Revenue989.151,022.59973.63804.83966.08
Operating Expense641.96655.01638.95554.08635.34
Operating Profit347.19367.58334.68250.75330.74
Depreciation13.1720.3217.4315.5214.72
Interest0.611.190.510.420.58
Tax94.18100.7195.6573.8794.76
Net Profit274.94277.18255204.70260.14

GlaxoSmithKline Technicals

GlaxoSmithKline Pharmaceuticals Ltd. EMA & SMA

₹2433.00

22.20 (0.92%)

↗ Bullish Moving Average

14

↘ Bearish Moving Average

2

Day EMA5 ₹2418.2
Day EMA10 ₹2398.6
Day EMA12 ₹2389.4
Day EMA20 ₹2360.2
Day EMA26 ₹2348.4
Day EMA50 ₹2343.2
Day EMA100 ₹2383.2
Day EMA200 ₹2467

GlaxoSmithKline Support and Resistance

Resistance

First Resistance₹2468.37
Second Resistance₹2496.33
Third Resistance₹2531.87

Support

First Support₹2404.87
Second Support₹2369.33
Third Support₹2341.37

Technical Indicators

Day RSI63.56
Day MFI75.88
Day ADX28.94
Day Commodity Channel Index74.20
William-24.07
Day MACD41.00
Day MACD Signal Line29.97
Day ATR58.24
Day ROC125-1.75
Day ROC2111.20

GlaxoSmithKline Shareholding Pattern

Held ByDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoter757575757575
FII4.54.54.954.64.6
DII7.37.87.787.77.7
Public13.212.712.41212.712.7

GlaxoSmithKline Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day38.41 K75.14 K51.12%
Week73.49 K1.06 L69.58%
1 Month1.25 L1.85 L67.65%
6 Month59.43 K97.89 K60.71%

GlaxoSmithKline SWOT Analysis

Strengths16
Weakness5
Opportunity1
Threats2

Companies with no Debt

Benjamin Graham Value Screen

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Volume Shockers

GlaxoSmithKline Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
29 May, 202657FINAL29 May, 2026Equity Share
30 May, 202542FINAL30 May, 2025Equity Share
07 Nov, 202412INTERIM07 Nov, 2024Equity Share
31 May, 202432FINAL31 May, 2024Equity Share
30 Jun, 202332FINAL30 Jun, 2023Equity Share
07 Jul, 202260SPECIAL08 Jul, 2022Equity Share
07 Jul, 202230FINAL08 Jul, 2022Equity Share
19 Jul, 202130FINAL20 Jul, 2021Equity Share
17 Jul, 202020SPECIAL20 Jul, 2020Equity Share
17 Jul, 202020FINAL20 Jul, 2020Equity Share

GlaxoSmithKline Stock Comparison

Financials
Rubicon Research Ltd.
Anthem Biosciences Ltd.
Sai Life Science Ltd.
Emcure Pharmaceuticals Ltd.
Mankind Pharma Ltd.
Piramal Pharma Ltd.
Price (₹)₹1,429₹754.95₹1,265₹1,805₹2,523₹176.50
% Change1.55%0.39%2.48%-0.25%-0.36%2.62%
Revenue TTM (₹ Cr)₹1,753.96₹2,124.33₹2,192.49₹9,203.54₹14,277.64₹8,869.07
Net Profit TTM (₹ Cr)₹246.74₹591.79₹348.91₹924.36₹1,912.93₹-325.93
PE TTM94.3071.6075.1037.1054.70-70.30
1 Year Return190.1431.9357.9843.820.21-14.62
ROCE24.3227.5618.3825.6514.322.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3390.00

-1.99%

GLAND

Gland Pharma Ltd.

₹ 2475.00

+0.22%

LAURUSLABS

Laurus Labs Ltd.

₹ 1535.50

+1.86%

ALKEM

Alkem Laboratories Ltd.

₹ 5676.00

+0.49%

BIOCON

Biocon Ltd.

₹ 418.25

+3.64%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6830.50

+0.26%

GRANULES

Granules India Ltd.

₹ 887.00

+0.56%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3366.00

+1.77%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1152.10

-0.60%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2284.50

+0.76%

WOCKPHARMA

Wockhardt Ltd.

₹ 1812.80

-1.01%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1568.90

-1.17%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1932.90

-0.30%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 19478.00

-0.33%

IPCALAB

Ipca Laboratories Ltd.

₹ 1780.10

+0.55%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2420.00

-1.00%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8115.00

+0.01%

PFIZER

Pfizer Ltd.

₹ 4720.00

+2.83%

ABBOTINDIA

Abbott India Ltd.

₹ 27340.00

+2.13%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4890.00

-0.17%

LUPIN

Lupin Ltd.

₹ 2496.00

-0.29%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1246.90

-1.78%

CIPLA

Cipla Ltd.

₹ 1442.00

+0.05%

FAQ's on GLAXO

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy